![]() |
||||
|
||||
|
|
||||
Re: hormone replacement and s/p tah bsoFrom: Dib Abdalla Chacur (chacur@rol.com.br)Tue Oct 26 20:01:11 1999
1 - HRT does not increase the Relative Risk of breast cancer during five years of use 2 - The relative risk of breast cancer increases to 1,1( 1,2) after ten years use, but the benefits ( osteoporosis, cardiovascular disease, etc ) are greater than this increasing in Relative Risk 3 - After fifteen years the Relative Risk increases up to 1,4. In this late situation the increasing of the RR is important ( it is difficult to find a woman that has made HRT for such long time) 4 - Progesterone does not protect breast tissue, then why use it when a patient underwent to TAH/BSO ? 5 - Exist several papers about the subjects above medical literature . Best regards Dib Jomyrwhipt@aol.com wrote:
> I was just precepting a Family Practice Resident and the woman presented for another complaint. In the presentation, the resident mentioned that this pt was s/p tah/bso and was taking prem-pro. I was under the impression and teaching that if you didn't have your uterus, then progesterone wasn't indicated. The resident, however, mentioned that the unopposed estrogen would increase the patients risk for breast cancer. I have two questions for the list.
-- DIB ABDALLA CHACUR Gynecology - Mastology Teacher of Gynecology and Head of Gynecology and Obstetrics Dpto. CAMPOS SCHOOL OF MEDICINE Campos - RJ - Brazil
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:32:36 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.